Graduated from the Pharmacy department of Shanghai Medical University (now Fudan University Shanghai Medical College); Accumulated over 14 years of professional experience in sales, marketing, and medical departments within multinational pharmaceutical corporations including Amgen, Roche Pharma & Roche Diagnostics, and GlaxoSmithKline (GSK), demonstrating extensive expertise in pharmaceutical commercial operations. Joined Tigermed Group in 2011 and founded Teddy Clinical Research Laboratory, a clinical research organization specializing in central laboratory services.

Graduated with a Bachelor's degree in Biomedical Engineering from ‌Chu Kochen Honors College, Zhejiang University‌, and obtained a Master of Science degree in Business Administration from School of Management, Fudan University‌. Previously served as a ‌Senior Biopharmaceutical Industry Analyst‌ at Sinolink Securities‌, where I was repeatedly honored as a ‌Top Healthcare Analyst‌ by prestigious industry awards including ‌New Wealth, Crystal Ball, and Golden Bull Awards‌. Later joined ‌Dian Diagnostics (SZSE: 300244)‌, holding key roles such as ‌Chairman’s Assistant, BD & Investment Director‌, and ‌General Manager of Yunnan Dian Diagnostics‌, accumulating ‌extensive management and operational experience in medical laboratory services‌. In 2020, joined ‌teddy clinical research laboratory as ‌Vice President‌, leveraging expertise to drive strategic initiatives in the healthcare sector.

Graduated from the Department of Medical Laboratory Science at Shanghai Jiao Tong University School of Medicine. Worked at the Institute of Hematology, Ruijin Hospital, and the Hematology Laboratory of Dongfang Hospital in Shanghai. With over 20 years of professional experience in hematological disease diagnostic technologies. Served as an inaugural committee member of the Hematopathology Working Group under the Hematologic Tumor Professional Committee of the Chinese Anti-Cancer Association.

Graduated from the University of New South Wales with a Ph.D. in Microbiology and Immunology. Specializing in long-term academic research and development of detection methodologies in bioinformatics and genomics, with over 20 peer-reviewed papers published in internationally recognized journals such as PNAS and ISME Journal ‌. Additionally, holds 4 national invention patents ‌.

He has worked in Shanghai Bio-Rad Antibody R&D Center, WuXi AppTec Bioanalytical Department, Frontage Pharmaceuticals (China) and other companies. With more than 10 years of experience in macromolecule bioanalysis and antibody research and development, he has supported more than 50 bioanalytical projects of domestic and foreign pharmaceutical companies, including monoclonal antibodies, double antibodies, triple antibodies, ADCs, fusion proteins, peptides, heparin, and vaccine products, and also cell and gene therapy products and other large and small molecule drugs. He has proficient practical experience and profound technical background in the fields such as macromolecule PK/Biomarker/ADA/NAb.

Obtained a master's degree in pharmaceutical analysis from Shenyang Pharmaceutical University. She has worked in well-known domestic and foreign research institutions and CRO companies such as the Pharmacokinetics Research Center of Shanghai Institute of Materia Medica, Shanghai Charles River, Shanghai Chempartner, focusing on the fields of in vivo drug analysis and pharmacokinetics to support preclinical, toxicological and clinical DMPK related research on new drugs. She has rich experience in clinical drug testing and has completed preclinical testing of hundreds of new drugs.

Graduated from the Medical Laboratory Science program at Qingdao University School of Medicine‌ and holds a Master of Business Administration from Donghua University. Previously employed at companies including WuXi AppTec, Covance, Quest Diagnostics, and Adicon, with over 15 years of clinical laboratory experience and CRO laboratory management experience.

Possesses over a decade of quality management experience in central laboratories‌ and bioanalytical laboratories‌4, with previous employment at WuXi AppTec‌ and MEDx. Experienced in undergoing nearly 100 audits from domestic and international pharmaceutical companies‌ and regulatory authorities, having supported multiple clinical trial project registration inspections‌. Demonstrates extensive practical expertise in quality management practices for drug clinical trial laboratories‌.

Graduated from the Department of Laboratory Medicine at Shanghai Jiao Tong University School of Medicine (formerly Shanghai Second Medical University)‌. Previously employed at the National Human Genome Center (South), Genecore Biotechnology, and Adicon Medical Laboratory Center‌. With nearly two decades of experience in Phase I-IV clinical trials and real-world study (RWS) research‌, has participated in and led multiple audits conducted by the National Medical Products Administration (NMPA), third-party auditing firms, and sponsors‌.

Graduated from the School of Basic Pharmaceutical Sciences‌ at Fudan University, with nearly a decade of foundational expertise in flow cytometry‌, molecular diagnostics‌, macromolecular analysis‌, and immunohistochemistry‌. Demonstrated project management capabilities in hematologic disease research, including scientific evaluation and coordination for multiple myeloma, myeloid leukemia, and lymphoma programs‌. Experienced in flow cytometry method development and validation for CAR-T‌, receptor occupancy‌, cytokine profiling‌, immunophenotyping‌, and minimal residual disease (MRD) detection‌.

Graduated from the ‌Department of Pathology/BMedical Sciences‌ at ‌Fudan University Shanghai Medical College‌. Held roles including ‌Engineer, Research Management Specialist, Application Engineer, National Training Manager‌, and ‌Senior Medical Advisor‌ at multinational organizations such as ‌Carl Zeiss Optical Instruments (Shanghai) International Trading Co., Ltd.‌, ‌Dako Medical Device Technical Services (Shanghai) Co., Ltd.‌, and ‌AstraZeneca China‌, gaining cross-functional expertise in medical technology and pharmaceutical operations. Joined teddy clinical research laboratory in 2017, leading the development of ‌pathological technology, central laboratory, and translational medicine platforms‌, with ‌extensive experience in advanced pathological techniques and centralized pathology services‌ for clinical research.